专业:细胞生物学
学历:博士
职称:副研究员
主要研究领域为: 肝病分子机制研究。
参与主持多项项目。
以第一作者和通讯作者发表的文章:
1.Herui Wei , Meixin Gao , Shiwei Wang , Junru Yang , Zhe Yu , Mengqi Li , Hongshan Wei# , Fan Xiao#. Life Sciences. 2025; 376:123763.
2.Herui Wei , Yifan Zhang , Meixin Gao , Junru Yang , Shiwei Wang , Xingang Zhou, Hongshan Wei#, Fan Xiao#. Molecular and Cellular Biochemistry. 2024;480(2):1183-95.
3.Xiao F, Gao M, Yang J, He L, Wei H*. FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress. Digestive Diseases and Sciences. 2021;66(9):3054-61.
4.Fan Xiao, Jing Zhang, Can Zhang, Wei An*. HSS protects SERCA in the mitochondria -associated membrane compartment and maintains intracellular Ca2+ homeostasis. Laboratory Investigation. 2017;97(3):289-301.
5.Fan Xiao, Chuan Song, Hongshan Wei*. Protein O glycosylation regulates activation of hepatic stellate cells. Inflammation. 2013;36(6):1248-52.
6.Fan Xiao, Kangkang Yu, Fang Dong, Yunlei Liang, Cheng Jun, Hongshan Wei*. The GABAB receptor inhibits activation of hepatic stellate cells. Digestive Diseases and Sciences. 2010; 55(2): 261-267.
7.Fan Xiao, Fang Dong, Du Bin, Xueyong Li, Jun Cheng, Hongshan Wei*.Serum levels of LHBs:Prognostic markers for HBeAg-negative patients with Adefovir Dipivoxiltreatment. Antiviral Therapy. 2009; 14(8):1149-1456.
8.Fan Xiao, Hongshan Wei*, Shujing Song, Guoli Li and Chuan Song. Polymorphismsin the promoter region of the angiotensinogen gene is associated with liver cirrhosis in patients with ch ronic hepatitis B. Journal of Gastroenterology and Hepatology. 2006; 21(9): 1488-1491.
9.李梦绮, 韦何锐, 罗婧, 安稳, 宋阿倩, 何玲玲, 杨君茹, 魏红山#,肖凡#. Fam172a 基因敲除活化ERK通路加重肝细胞脂毒性损伤的研究.医学分子生物学杂志. 2024;21(6):501-7.
10.李梦绮, 韦何锐, 安稳, 罗婧, 何玲玲, 杨君茹, 肖凡#, 魏红山#. Fam172 a基因敲除加剧非酒精性脂肪性肝病的机制研究. 医学分子生物学杂志. 2024;21(1):1-8.
11.肖凡, 董芳, 乔雍, 常路丝, 张仁雯, 成军, 魏红山*.O-糖基转移酶、Glt25D2与乙型肝炎包膜蛋白大蛋白的分泌有关.中华实验和临床感染病杂志(电子版). 2013; 7(5):633-636.
12.肖凡, 乔雍, 张仁雯, 常路丝, 成军, 魏红山*.抑制O-糖基化修饰促进乙型肝炎病毒的释放.中华实验和临床感染病杂志(电子版). 2013; 7(4):495-498.
13.肖凡,张毅,张剑平,曾辉,魏红山*. r-氨基丁酸对肝星状细胞功能的影响.中华肝脏病杂志. 2007; 15(7):545-546.